$HSTM
HealthStream Inc

2015 Q2 Form 10-Q Financial Statement

#000119312515272918 Filed on July 31, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $52.15M $42.48M
YoY Change 22.76% 33.07%
Cost Of Revenue $22.43M $18.74M
YoY Change 19.71% 45.58%
Gross Profit $29.71M $23.74M
YoY Change 25.17% 24.62%
Gross Profit Margin 56.98% 55.89%
Selling, General & Admin $17.08M $12.61M
YoY Change 35.41% 22.84%
% of Gross Profit 57.48% 53.13%
Research & Development $5.815M $4.294M
YoY Change 35.42% 54.57%
% of Gross Profit 19.57% 18.09%
Depreciation & Amortization $4.256M $2.722M
YoY Change 56.36% 43.49%
% of Gross Profit 14.32% 11.47%
Operating Expenses $22.89M $16.91M
YoY Change 35.41% 29.6%
Operating Profit $2.564M $4.110M
YoY Change -37.62% 0.1%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$44.00K $23.00K
YoY Change -291.3% -17.86%
Pretax Income $2.520M $4.133M
YoY Change -39.03% -0.02%
Income Tax $1.047M $1.769M
% Of Pretax Income 41.55% 42.8%
Net Earnings $1.473M $2.364M
YoY Change -37.69% -2.39%
Net Earnings / Revenue 2.82% 5.57%
Basic Earnings Per Share $0.05 $0.09
Diluted Earnings Per Share $0.05 $0.08
COMMON SHARES
Basic Shares Outstanding 29.23M shares 27.57M shares
Diluted Shares Outstanding 29.62M shares 28.04M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $139.9M $111.8M
YoY Change 25.13% 10.23%
Cash & Equivalents $54.49M $60.86M
Short-Term Investments $85.40M $50.90M
Other Short-Term Assets $6.511M $4.038M
YoY Change 61.24% 34.29%
Inventory
Prepaid Expenses
Receivables $33.41M $29.79M
Other Receivables $0.00 $0.00
Total Short-Term Assets $198.9M $160.4M
YoY Change 24.0% 23.58%
LONG-TERM ASSETS
Property, Plant & Equipment $11.28M $9.468M
YoY Change 19.16% 26.39%
Goodwill $83.99M $43.23M
YoY Change 94.27% 46.89%
Intangibles
YoY Change
Long-Term Investments $2.800M
YoY Change
Other Assets $1.217M $961.0K
YoY Change 26.64% 26.78%
Total Long-Term Assets $172.5M $81.02M
YoY Change 112.89% 44.39%
TOTAL ASSETS
Total Short-Term Assets $198.9M $160.4M
Total Long-Term Assets $172.5M $81.02M
Total Assets $371.4M $241.4M
YoY Change 53.83% 29.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.049M $1.319M
YoY Change 131.16% -17.82%
Accrued Expenses $9.658M $9.338M
YoY Change 3.43% 9.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $86.96M $75.05M
YoY Change 15.88% 87.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.598M $615.0K
YoY Change 322.44% -8.89%
Total Long-Term Liabilities $2.598M $615.0K
YoY Change 322.44% -8.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $86.96M $75.05M
Total Long-Term Liabilities $2.598M $615.0K
Total Liabilities $89.56M $75.66M
YoY Change 18.37% 86.02%
SHAREHOLDERS EQUITY
Retained Earnings -$2.835M -$13.11M
YoY Change -78.38% -38.95%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $271.9M $157.2M
YoY Change
Total Liabilities & Shareholders Equity $371.4M $241.4M
YoY Change 53.83% 29.86%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income $1.473M $2.364M
YoY Change -37.69% -2.39%
Depreciation, Depletion And Amortization $4.256M $2.722M
YoY Change 56.36% 43.49%
Cash From Operating Activities $10.12M $12.91M
YoY Change -21.61% 72.13%
INVESTING ACTIVITIES
Capital Expenditures -$3.280M -$2.540M
YoY Change 29.13% 76.39%
Acquisitions
YoY Change
Other Investing Activities -$56.01M -$8.300M
YoY Change 574.82% -295.75%
Cash From Investing Activities -$59.30M -$10.85M
YoY Change 446.54% -488.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 68.90M -240.0K
YoY Change -28808.33% -151.06%
NET CHANGE
Cash From Operating Activities 10.12M 12.91M
Cash From Investing Activities -59.30M -10.85M
Cash From Financing Activities 68.90M -240.0K
Net Change In Cash 19.72M 1.820M
YoY Change 983.52% -83.09%
FREE CASH FLOW
Cash From Operating Activities $10.12M $12.91M
Capital Expenditures -$3.280M -$2.540M
Free Cash Flow $13.40M $15.45M
YoY Change -13.27% 72.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31639938 shares
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60862000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31640000 shares
CY2015Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31640000 shares
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1831000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
271903000
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2598000
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16226000
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
64945000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3049000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
301000
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9658000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2835000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
371350000
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4232000
CY2015Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
274816000
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28482000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
86963000
CY2015Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
7480000
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-78000
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5654000
CY2015Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
20752000
CY2015Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
29051000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1217000
CY2015Q2 us-gaap Prepaid Royalties
PrepaidRoyalties
15607000
CY2015Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
13634000
CY2015Q2 us-gaap Acquired Finite Lived Intangible Asset Residual Value
AcquiredFiniteLivedIntangibleAssetResidualValue
47200000
CY2015Q2 us-gaap Assets
Assets
371350000
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33405000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11282000
CY2015Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
85408000
CY2015Q2 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1512000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
198868000
CY2015Q2 us-gaap Other Assets Current
OtherAssetsCurrent
6511000
CY2015Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4730000
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
59603000
CY2015Q2 us-gaap Goodwill
Goodwill
83990000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54493000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39764000
CY2015Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5983000
CY2015Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
2756000
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1932000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59537000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27677000 shares
CY2014Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27677000 shares
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2311000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
167859000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2649000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13834000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53716000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4753000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
331000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7224000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7030000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
257262000
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3657000
CY2014Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
174926000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26105000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
77259000
CY2014Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
9255000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5838000
CY2014Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
18114000
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
25133000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2037000
CY2014Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
13030000
CY2014Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
12706000
CY2014Q4 us-gaap Assets
Assets
257262000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33167000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9442000
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
38973000
CY2014Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1678000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
174611000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5414000
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4554000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14795000
CY2014Q4 us-gaap Goodwill
Goodwill
41914000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81995000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35547000
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5860000
CY2014Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1757000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
354000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
22102000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
119000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27975000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
465000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27510000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.423 pure
us-gaap Payments For Software
PaymentsForSoftware
2689000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2423000
us-gaap Net Income Loss
NetIncomeLoss
4311000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
152000
us-gaap Sales Revenue Net
SalesRevenueNet
80825000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
705000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12501000
us-gaap Operating Income Loss
OperatingIncomeLoss
7408000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-53000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
68000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
3841000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
32046000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
265000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
22000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
261000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
22000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4333000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3558000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7476000
us-gaap Stock Issued1
StockIssued1
2246000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3165000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14689000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14199000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-20826000
us-gaap Costs And Expenses
CostsAndExpenses
73417000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
49000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7840000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3165000
us-gaap Other Noncash Expense
OtherNoncashExpense
752000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-520000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1325000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
462000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
834000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10592000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
29098000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-992000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
2721000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5123000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
35663000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
70000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
19131000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001095565
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
748000
us-gaap Sales Revenue Net
SalesRevenueNet
99301000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2347000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
98014000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
424000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
88075000
us-gaap Operating Income Loss
OperatingIncomeLoss
7354000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28843000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
374000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28469000 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Trading Symbol
TradingSymbol
HSTM
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.427 pure
us-gaap Payments For Software
PaymentsForSoftware
3566000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4054000
us-gaap Net Income Loss
NetIncomeLoss
4195000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-820000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-35000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
76768000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-41000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
628000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-41000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4154000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
2578000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-3055000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7319000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-471000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
28000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3124000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5713000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17675000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-143548000
us-gaap Costs And Expenses
CostsAndExpenses
91947000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
96915000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10460000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
823000
us-gaap Other Noncash Expense
OtherNoncashExpense
386000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
98014000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
645000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-27502000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
277000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2347000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13678000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
28000000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
29915000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1703000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-1776000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7509000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
42625000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
119000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
42076000
hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
70000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28043000 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
476000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27567000 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
2364000
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
42476000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4110000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4294000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
450000
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14000
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2378000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4133000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1769000
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7251000
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
38366000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5361000
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2722000
CY2014Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
18738000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29617000 shares
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
383000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29234000 shares
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
1473000
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
52145000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2564000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-62000
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-62000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1411000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2520000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1047000
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10328000
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
49581000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5815000
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1938000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6750000
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4256000
CY2015Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
22432000

Files In Submission

Name View Source Status
0001193125-15-272918-index-headers.html Edgar Link pending
0001193125-15-272918-index.html Edgar Link pending
0001193125-15-272918.txt Edgar Link pending
0001193125-15-272918-xbrl.zip Edgar Link pending
d129867d10q.htm Edgar Link pending
d129867dex102.htm Edgar Link pending
d129867dex311.htm Edgar Link pending
d129867dex312.htm Edgar Link pending
d129867dex321.htm Edgar Link pending
d129867dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hstm-20150630.xml Edgar Link completed
hstm-20150630.xsd Edgar Link pending
hstm-20150630_cal.xml Edgar Link unprocessable
hstm-20150630_def.xml Edgar Link unprocessable
hstm-20150630_lab.xml Edgar Link unprocessable
hstm-20150630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending